|
Oct 9
|
Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles
|
|
Sep 24
|
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan
|
|
Aug 27
|
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?
|
|
Aug 11
|
Co-Diagnostics Second Quarter 2024 Earnings: Beats Expectations
|
|
Aug 8
|
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results
|
|
Jul 29
|
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago
|
|
Jul 25
|
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
|
|
Jun 18
|
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
|
|
Jun 14
|
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
|
|
May 13
|
Co-Diagnostics First Quarter 2024 Earnings: Misses Expectations
|
|
May 10
|
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
|
|
Apr 25
|
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
|
|
Apr 24
|
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
|
|
Apr 12
|
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
|
|
Apr 4
|
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
|
|
Mar 21
|
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address
|
|
Mar 18
|
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
|
|
Mar 16
|
We Think Co-Diagnostics (NASDAQ:CODX) Needs To Drive Business Growth Carefully
|
|
Mar 16
|
Co-Diagnostics Full Year 2023 Earnings: Misses Expectations
|